Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice history

Akebia Therapeutics, Inc. News

Cramer's Mad Money Recap: T-Mobile, Biogen

Jim Cramer explains why he things the New York Stocks Exchange still matters -- and he's happy to be back on the floor.

Heat Biologics Takes Beating After Pricing $12 Million Stock Offering

Heat Biologics Inc. nosedived after the Durham, North Carolina-based biopharmaceutical company filed for a share offering pricing expected to hit $12 million.

Axovant Plummets On Disappointing Alzheimer's Treatment Data - Biotech Movers

The company said Tuesday its Phase 3 study of intepirdine in patients with Alzheimer's disease did not achieve its co-primary efficacy endpoints.Meanwhile, shares of Genocea Biosciences Inc. were down, after the Cambridge, Mass.-based company announced a shift to immuno-oncology and a focus on developing neoantigen cancer vaccines.

Biotech Movers: Impax Shares Jump On FDA Approval for Generic Version of Concerta

Impax Laboratories, Akebia Therapeutics and Alder BioPharmaceuticals were among the biotech movers in premarket trading on July 17.

Biotech Movers: Akebia Shares Down After Pricing Stock Offering

Akebia Therapeutics, Sarepta Therapeutics and Esperion Therapeutics were among the biotech stock movers in premarket trading on June 29.

Breaking News

Elon Musk Throws Dogecoin a Lifeline

Elon Musk will soon allow Dogecoin to purchase SpaceX merchandise.

Disney Fans Angry, Excited About New Guardians of the Galaxy Ride

The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.

Aurora Cannabis Slashing Weed Capacity in Profitability Push

Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.

Costco Beats Q3 Sales Forecast, Membership Revenues Near $1 Billion

Costco took in $984 million in new membership fee in its fiscal third quarter, helping the bulk retailer top Street forecasts for topline revenues.